Cite
MLA Citation
Aurélien Mazeraud et al.. “Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial.” Lancet, vol. 10, no. 2, 2022, pp. 158–166. http://access.bl.uk/ark:/81055/vdc_100150532318.0x00000c